Immunic Inc (NASDAQ: IMUX) completes the main analysis of Phase 1 CALVID-1 trial evaluating its lead asset, IMU-838. It is a selective oral DHODH inhibitor used in hospitalized patients with ...

Immunic (IMUX) announced that the data from its phase 1/1b clinical trial of IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, has been published in ...

Serial Studio includes several visualization options, including raw line graphs, bar/level indicator, dial indicator, the artificial horizon for IMU data, or a map widget.

NEW YORK, Dec. 4, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic ...

NEW YORK, Aug. 2, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic ...

Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at ...

Fusionex and IMU introduce Big Data Analytics to accelerate medical education and research, pioneering the country’s first AI-powered medical R&D.

His 3D Millennium Falcon model gets orientation data from his IMU as an an HID device. The hardware involved is an MPU6050 6-axis sensor that is interfaced with a Teensy 3.2 board.

To develop the algorithm, the researchers used IMU sensor-based gait data and conventional step length data from 472 subjects ...